Skip to main content
. 2020 Nov 17;11:581673. doi: 10.3389/fimmu.2020.581673

Figure 3.

Figure 3

Apremilast modulated naïve CD4+ T-cells in vitro. Cells isolated from the DLNs stimulated with IRBP1-20 for 3 days with or without apremilast were analyzed by flow cytometry. (A–I) Apremilast suppressed the frequency and number of IL17A-, IFNγ-, and TNFα-producing cells. (J–L) Apremilast upregulated the proportion and population of CD4+CD25+Foxp3+ T-cells. Data expressed as mean±SD, **P < 0.01, ***P < 0.001, N = 6.